Mejora de la Inmunización en los Países en Desarrollo
- Health care
- Infant health
- Maternal health
- Sustainable development
- Vulnerable populations
- Technology
- Social enterprise
Ejemplo: Guíenos a través de un ejemplo/s específico/s de cómo esta solución hace la diferencia; incluya sus actividades principales.
Mercado: ¿Quién mas está abordando el problema aquí descrito ? ¿Cómo difiere el proyecto propuesto de esos enfoques?
Historia fundacional
Mark
Thomas
VaxTrac
, KY, Jefferson County
, LI
1-5 años
La información que brindes aquí será usada para llenar las partes de tu perfil que hayan sido dejadas en blanco, como intereses, organización, y sitio web. Ninguna información de contacto será hecha pública. Por favor desmarca esta casilla si no deseas que esto suceda..
Operando entre 1-5 años
We envision a world where every child, regardless of background, has equal access to lifesaving vaccines. Every year, more than 24 million children will not receive the most basic vaccines, and 2.5 million of which will die from vaccine-preventable disease. Ambitious as it may seem, we intend to drive that number to zero. It is encouraging that there is so much international focus and funding to bring vaccination to the forefront of development efforts. However, it is unacceptable that we do not make every available effort to ensure we do not waste a single dollar or a single dose. The goal of our initiative is to reduce vaccine wastage making more doses available and to strengthen the entire delivery system with actionable data.
We have completed the design of our system as well as prototype testing in rural India. To date, we have proven the biometrics work at a high reliability rate and that the technology can stand up to the harsh environments for which it was specifically designed. The currently ongoing pilot project has the system deployed in two regions in southern Benin. Collectively, we are covering a total population of roughly 400,000 people. Upon successful completion of the pilot project, we expect to be prove that we reduced vaccine wastage, increased the coverage rate and reduced the total vaccination system cost per fully immunized child.
In the next five years, we expect to have the system deployed at a national scale in at least several medium-size countries. We also expect to have sub-national projects in another dozen countries, with plans to scale those up to national coverage. In total, we expect that our systems will be covering a total population of 50-100 million people. One key benefit will be a reduction of the vaccine wastage rate, the implication of which is that a country can immunize more people with the same number of vaccines. Coverage level goes up (more children get immunized) and the cost efficiency goes up (higher coverage at the same cost).
Demonstrate success on a small scale and build foundation for continued growth
Complete pilot project in Benin and publish results
Begin larger deployments in two new countries
Initiate partnerships with at least six organizations that have operations in new countries
Identify and resolve issues faced as projects are brought to national scales
Work with partners to draft and approve a plan for ramp-up from pilot project to national scale
Build a detailed cost model for what is required to scale (hardware, training, logistics, etc.)
Drive down unit costs at least 50% by completing another design iteration and initiating new procurement strategies
Our most fruitful partnerships are with the managers and implementers of frontline health service delivery. We work closely with the WHO and UNICEF at both the country level as well as at international and programmatic levels. Within each country, we also work directly with representatives from the Ministry of Health and other NGOs that operate health facilities. We are also leveraging the network of some of our funders (e.g. Gates Foundation) to forge new relationships with other organizations merging innovation and health care in developing countries.
In the long term, we target the 73 GAVI-eligible countries, which are all of the countries with a per capita GNI of under $1,500. In the short term, we are ensuring that we validate the impact of our system across a broad range of environments, geographies, and levels of infrastructure. We have plans for projects in three different countries, each of which presents unique challenges. We have a pilot project in Benin and will be initiating new projects in the next few months in Nepal and Ecuador.
We give our team significant freedom and empower them to make decisions and plans. Clearly this only works because we have been very selective as to who we bring on board; this is not an environment in which most will thrive, or even survive. We also embrace both lean and flat organizational principles. No one has to report to an office; we all work remotely and at our own pace and in our own preferred style. We also do not burden the organization with strict reporting structures. Everyone involved knows what the end goal is and they have been given the power to make that happen.
Funding is an issue for every organization, non-profit and corporate alike. I think it goes without saying that it is a constant stressor and one that too often takes time away from our people making a real impact. In addition to funding, a major need is building relationships with other NGOs or government agencies that have boots on the ground in these countries providing the vaccinations.